BetterLife Pharma Appoints New Corporate Advisor: André Beaudry
Vancouver, British Columbia, April 03, 2025 – BetterLife Pharma Inc. (BETR / BETRF / NPAU), an innovative biotech company, is thrilled to announce the appointment of André Beaudry as Corporate Advisor. With over three decades of experience under his belt, Mr. Beaudry brings a wealth of knowledge and expertise to the BetterLife team.
A Seasoned Professional
Mr. Beaudry’s impressive background includes extensive experience in fundraising, government relations, national and international program management, and governance. He has worked with various organizations in the biotech, healthcare, and technology sectors, making him an invaluable addition to BetterLife.
Fundraising and Government Relations
Throughout his career, Mr. Beaudry has successfully raised millions of dollars for numerous projects and initiatives. His expertise in fundraising will be instrumental in securing the necessary resources for BetterLife’s research and development efforts. Moreover, his strong government relations background will help the company navigate the regulatory landscape more effectively.
Program Management and Governance
Mr. Beaudry’s experience in program management will enable BetterLife to execute its strategic initiatives more efficiently. His understanding of governance will also ensure that the company maintains the highest standards of transparency and accountability.
A Positive Impact on You
As a BetterLife shareholder, this appointment signifies the company’s commitment to continued growth and success. With Mr. Beaudry’s expertise, BetterLife is well-positioned to overcome any challenges it may face and deliver value to its shareholders.
A Global Impact
Beyond BetterLife’s shareholders, Mr. Beaudry’s appointment will have a positive impact on the biotech industry as a whole. His extensive experience and knowledge will contribute to the advancement of scientific research and the development of innovative treatments and therapies.
Conclusion
BetterLife Pharma’s appointment of André Beaudry as Corporate Advisor is an exciting development for the company and the biotech industry. Mr. Beaudry’s impressive background and expertise in fundraising, government relations, program management, and governance will undoubtedly contribute to BetterLife’s continued growth and success. As a shareholder, you can look forward to the company’s progress, while the world benefits from the advancements in scientific research and the development of innovative treatments and therapies.
- BetterLife Pharma appoints André Beaudry as Corporate Advisor
- Mr. Beaudry brings over 30 years of experience in fundraising, government relations, program management, and governance
- His appointment signifies BetterLife’s commitment to continued growth and success
- Mr. Beaudry’s expertise will contribute to the advancement of scientific research and the development of innovative treatments
